Heron Net Invested Capital from 2010 to 2024

HRTX Stock  USD 1.18  0.04  3.28%   
Heron Therapeuti Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
139.8 M
Current Value
196.2 M
Quarterly Volatility
82.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Heron Therapeuti over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Heron Therapeuti's Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Pretty Stable
   Net Invested Capital   
       Timeline  

Heron Net Invested Capital Regression Statistics

Arithmetic Mean202,119,798
Geometric Mean190,747,810
Coefficient Of Variation40.73
Mean Deviation59,454,774
Median159,820,000
Standard Deviation82,323,438
Sample Variance6777.1T
Range269.7M
R-Value0.27
Mean Square Error6773.5T
R-Squared0.07
Significance0.33
Slope4,937,042
Total Sum of Squares94880.1T

Heron Net Invested Capital History

2024196.2 M
2023139.8 M
2022162.9 M
2021226.7 M
2020243.5 M
2019409.5 M
2018374.7 M

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital139.8 M196.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.